Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF VariantsPaul M. Steed, Bassil I. Dahiyat, Cheryl Chan et al.|Science|2003Cited by 259
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primatesJonathan Zalevsky, Chris E. Lawrence, Irene Leung et al.|Blood|2008Cited by 101
XmAb™2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies.Chris E. Lawrence, David F. Carmichael, Phil W. Hammond et al.|Blood|2007Cited by 11
XmAb®5574, An Fc Engineered Humanized Anti-CD19 Monoclonal Antibody, Has Potent in Vitro and in Vivo Activities, and Has the Potential for Treating B Cell MalignanciesChris E. Lawrence, David F. Carmichael, Holly Horton et al.|Blood|2008Cited by 1